Skip to main content
. 2011 Sep 17;79(4):729–747. doi: 10.3797/scipharm.1107-19

Tab. 1.

Cytotoxicity attenuation of intercalating antitumor agents by caffeine.

Compound IC50 (μM)a
no caffeine with caffeineb
Berberine 50.0(4.3) 511(59)
Camptothecin 9.21(1.41) 335(31)
Chelerythrine 32.1(0.5) 37.4(0.8)
Doxorubicin 11.4(2.2) 31.7(3.9)
Ellipticine 12.8(0.5) 333(7)
Sanguinarine 5.78(0.22) 6.66(0.16)
a

Standard deviations in parentheses.

b

Caffeine concentration = 1030 μM.